| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.0043 | 1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.0067 | 1 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.0064 | 1 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |